Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.J Am Coll Cardiol. 2012; 59: 857-881
- Percutaneous coronary intervention use in the United States defining measures of appropriateness.JACC Cardiovasc Interv. 2012; 5: 229-235
- Appropriate use criteria to reduce underuse and overuse of revascularization.J Am Coll Cardiol. 2013; 61: 2024
- Optimal medical therapy with or without PCI for stable coronary disease.N Engl J Med. 2007; 356: 1503-1516
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Veterans Affairs cooperative studies program no. 424.Am Heart J. 2006; 151: 1173-1179
- Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.J Am Coll Cardiol. 1995; 25: 333-341
- Monitoring the quality of life in patients with coronary artery disease.Am J Cardiol. 1994; 74: 1240-1244
- Health status predicts long-term outcome in outpatients with coronary disease.Circulation. 2002; 106: 43-49
- Clinically important differences in health status for patients with heart disease: an expert consensus panel report.Am Heart J. 2004; 147: 615-622
- Effect of PCI on quality of life in patients with stable coronary disease.N Engl J Med. 2008; 359: 677-687
- Indications for Selected Medical and Surgical Procedures: A Literature Review and Ratings of Appropriateness: Coronary Artery Bypass Surgery.RAND, Santa Monica1986 (Publication R-3204/2-CWF-HF-HCFA-PMT-RWJ)
- Consensus methods: characteristics and guidelines for use.Am J Public Health. 1984; 74: 979-983
- The quality of care and the quality of measuring it.N Engl J Med. 1993; 329: 1263-1265
- What is inappropriate care?.JAMA. 1988; 260: 540-541
- Some observations on attempts to measure appropriateness of care.BMJ. 1994; 309: 730-733
- Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization.N Engl J Med. 1996; 335: 1888-1896
- Appropriateness criteria for coronary angiography in angina: reliability and validity.Ann Intern Med. 2008; 149: 221-231
- Validity of criteria used for detecting underuse of coronary revascularization.JAMA. 1995; 274: 632-638
- Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization.N Engl J Med. 2001; 344: 645-654
- Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease.J Am Coll Cardiol. 2012; 60: 1876-1884
- Appropriateness of percutaneous coronary intervention.JAMA. 2011; 306: 53-61
- Appropriateness of percutaneous coronary interventions in Washington state.Circ Cardiovasc Qual Outcomes. 2012; 5: 445-453
- Appropriateness of coronary revascularization for patients without acute coronary syndromes.J Am Coll Cardiol. 2012; 59: 1870-1876
- ACC/AHA/SCAI/AMA-convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on performance measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for performance improvement, and the National Committee for Quality Assurance.J Am Coll Cardiol. 2014; 63: 722-745
- As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good.J Am Coll Cardiol. 2014; 63: 1634-1635
- Is optimal medical therapy as used in the COURAGE trial feasible for widespread use?.Curr Treat Options Cardiovasc Med. 2011; 13: 16-25
- The truth and consequences of the COURAGE trial.J Am Coll Cardiol. 2007; 50: 1598-1603
- Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.Circulation. 2008; 117: 1283-1291
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)—Full Text View—ClinicalTrials.gov. Available at: http://clinicaltrials.gov/show/NCT01471522. Accessed July 24, 2014.
Disclaimer: The views expressed in this report represent those of the authors and do not necessarily represent the official views, position, or policy of the Department of Veterans Affairs or the US government.
See page 172 for disclosure information.